[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 18.206.12.79. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
The Cutting Edge: Challenges in Medical and Surgical Therapies
Mar 2012

Acitretin- and Tumor Necrosis Factor Inhibitor –Resistant Acrodermatitis Continua of Hallopeau Responsive to the Interleukin 1 Receptor Antagonist Anakinra

Arch Dermatol. 2012;148(3):297-299. doi:10.1001/archdermatol.2011.2473

Acrodermatitis continua of Hallopeau is a variant of pustular psoriasis, which can be very difficult to treat. We describe a patient who could not be controlled with most approved drugs for psoriasis including acitretin, methotrexate, tumor necrosis factor (TNF) inhibitors, and ustekinumab. The interleukin 1 (IL-1) receptor antagonist anakinra was rapidly effective and allowed controlling fever and pustulation. Targeting IL-1 could be an important alternative to the classic treatments of pustular psoriasis.

×